Furthermore, Src was not only required to maintain cancer stem cell properties but also participated in the pathway that controls the EMT.52, 53 Unsurprisingly, the expression of vimentin and CD133 was decreased while the expression of E‐cadherin was increased after the inhibition of Src. The gene discussed is CDH1; the disease is cancer.